June 2020
Corporate HQ
Boston, US

X-Chem is the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services. DEL technology allows customers to screen billions of compounds simultaneously against a single biological target, and is an innovative and high growth segment of the market.

From its US headquarters in Waltham, and leveraging a proprietary DEL platform with libraries containing over 200 billion small molecules, X-Chem has supported drug discovery programmes for partners throughout the US, Europe and Japan and has licensed over seventy research programs to companies, comprising hundreds of novel chemical entities.

Enablement & Alignment

Industry leading DNA-Encoded Libraries platform.

Focus on high quality science and innovation with an extensive track record of supporting pharma customers in complex drug discovery programs.

Capability & Capacity

Significant expansion of the business development team to capitalise on the opportunity with increased focus on digital presence.

Organic investments in back office infrastructure to provide a scalable platform for growth.

Adding adjacent capabilities and building geographic presence to better serve customer base with high quality science.

Building Strategic Footprints

Continued focus on R&D to maintain and advance scientific leadership and innovation.

Focus on expanding customer reach by broadening service offering and targeting European and Asian markets.

Targeting emerging and mid-sized customers with a new more accessible offering.